p53 Modulates the Gut‐Liver Axis via PI3K/AKT/Wnt Signaling Pathways in Type 2 Diabetes
The FASEB Journal · 2025
DOI: 10.1096/fj.202500755rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Qiang Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Wannan Medical College, Wuhu, Anhui, China. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Diabetes Mellitus, Type 2, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC), Outstanding Youth Scientific Research Program for Universities in Anhui Province, Horizontal Scientific Research Project of Wannan Medical College.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The p53 protein has been identified as a critical regulator of metabolic processes in a variety of diseases, including obesity, diabetes, liver disease, and cardiovascular disease. However, the precise function and mechanism of action of p53 in the regulation of glucose‐lipid metabolism through the enterohepatic axis remain to be fully elucidated. The present study investigated the effects of p53 deficiency on type 2 diabetic mice and demonstrated that p53 deficiency resulted in more severe impairment of glucose tolerance and insulin tolerance. Furthermore, the study revealed that p53 can influence hepatic glucose metabolism via the PI3K/AKT pathway. Additionally, p53 deletion has been observed to modify intestinal function and the intestinal microenvironment, thereby correlating with intestinal function and microbiota composition in T2DM mice. Specifically, p53 knockout mice exhibited impaired ileal digestion, absorption, and colonic secretion after a HFD (HFD). Additionally, the richness and diversity of their intestinal microbiota were reduced, and these mice exhibited symptoms such as obesity, fat infiltration, defecation abnormalities, and severe abnormalities of glucose and insulin tolerance. The expression levels of β‐catenin and c‐Myc proteins were found to be elevated in mice fed a HFD, while the expression of these proteins was diminished in mice with p53 knockout, compared to those on a normal diet. The experimental results suggest that p53 affects insulin secretion through the PI3K/AKT signaling pathway and regulates the distribution of intestinal microbiota through the Wnt signaling pathway, which in turn affects the development of type 2 diabetes mellitus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Wannan Medical College, Wuhu, Anhui, China.
- School of Forensic Medicine, Wannan Medical College, Wuhu, Anhui, China.
- School of Pharmaceutical Sciences, Wannan Medical College, Wuhu, Anhui, China.
- School of Clinical Medicine, Wannan Medical College, Wuhu, Anhui, China.
- Schools of Medical Imaging, Wannan Medical College, Wuhu, Anhui, China.
- Anhui Digital Brain Engineering Research Center, the First Affiliated Hospital of Wannan Medical College, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China.
ORCID-Profile: Zhiliang Xu
Förderung
- National Natural Science Foundation of China (NSFC)
- Outstanding Youth Scientific Research Program for Universities in Anhui Province
- Horizontal Scientific Research Project of Wannan Medical College
- Young and middle-aged scientific research fund of Wannan Medical College
- National Innovation and Entrepreneurship Training Program for Undergraduates
- University Natural Science Research Project of Anhui Province
- Wannan Medical College
Zitieren
APA
Li, Q., Zhang, L., Sun, Y., Du, Z., Xu, S., Wang, X., Wei, S., Tao, Y., Li, B., Jiang, J., Di, G., Huang, Y., & Xu, Z. (2025). p53 Modulates the Gut‐Liver Axis via PI3K/AKT/Wnt Signaling Pathways in Type 2 Diabetes. The FASEB Journal. https://doi.org/10.1096/fj.202500755rr
Vancouver
Li Q, Zhang L, Sun Y, Du Z, Xu S, Wang X, et al. p53 Modulates the Gut‐Liver Axis via PI3K/AKT/Wnt Signaling Pathways in Type 2 Diabetes. The FASEB Journal. 2025. doi:10.1096/fj.202500755rr
BibTeX
@article{Li2025,
author = {Li, Qiang and Zhang, Lei and Sun, Yuhan and Du, Zhaoyang and Xu, Shoulong and Wang, Xuejing and Wei, Shanshan and Tao, Yinan and Li, Bin and Jiang, Jing and Di, Guangfu and Huang, Yanjiao and Xu, Zhiliang},
title = {p53 Modulates the Gut‐Liver Axis via PI3K/AKT/Wnt Signaling Pathways in Type 2 Diabetes},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202500755rr}
}
EUVIMED